title: [Study of use of psychiatric drugs in primary care].
abstract: OBJECTIVE
  To get to know the profile of use of antidepressants (AD) and tranquilizers-hypnotics (T-H) in primary care in Catalonia.
  
  
  METHODS
  Transversal, observational, epidemiological study of prescription-indication.
  
  
  METHODS
  Health centres in Catalonia, Spain.
  
  
  METHODS
  Included, using consecutive sampling, patients on treatment with AD and/or T-H.
  
  
  METHODS
  The variables studied were: age, sex, type and number of drugs, treatment schemes, reason for prescribing, and the health professional who initiated it.
  
  
  RESULTS
  1613 drugs were evaluated: 43% were AD and 57% were T-H. The sub-groups most prescribed were: selective serotonin reuptake inhibitors (SSRI) (31.6%) and short half-life (32.9%) and long half-life (19.8%) benzodiazepines (BZD). We included 998 patients, 76% of the participants were women. The average age was 52.24 years (range, 16-96). 19.9% (n=199) received treatment with AD only, 34.3% (n=342) with T-H only, and 45.8% (n=457) combined treatment. The mean number of drugs per patient was 1.6. The main reasons for prescribing were: major depression or dysthymia (60.2%; n=417) for AD and generalised anxiety (33.3%; n=306) and insomnia (23.9%; n=220) for T-H. 39.8% (n=268) of the AD and 51.0% (n=441) of T-H had been prescribed for more than 1 year.
  
  
  CONCLUSIONS
  The described profile of the use of psychiatric drugs suggests the need to reconsider the over-prescribing of BDZ and improve coordination between psychiatrists and primary care doctors.
authors.affiliation: Servei d'Atenció Primària Mataró-Maresme, ICS, Mataró, Barcelona, Spain. cvedia.bnm.ics@gencat.net
authors.forename: C
authors.initials: C
authors.lastname: Vedia Urgell
authors.forename: S
authors.initials: S
authors.lastname: Bonet Monne
authors.forename: C
authors.initials: C
authors.lastname: Forcada Vega
authors.forename: N
authors.initials: N
authors.lastname: Parellada Esquius
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000928:Antidepressive Agents / Q000627:therapeutic use; D011307:Drug Prescriptions; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy / Q000453:epidemiology; D008875:Middle Aged; D011320:Primary Health Care; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D012737:Sex Factors; D013030:Spain / Q000453:epidemiology; D014149:Tranquilizing Agents / Q000627:therapeutic use
chemical_list: D000928:Antidepressive Agents; D006993:Hypnotics and Sedatives; D011619:Psychotropic Drugs; D014149:Tranquilizing Agents